Related Experiment Videos
The molecular genetics of Mycobacterium tuberculosis
1Department of Biological Sciences, University of Pittsburgh, PA 15260, USA.
Current Topics in Microbiology and Immunology
|January 1, 1996
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Activity of a three-phage combination against Mycobacterium tuberculosis in disease-relevant conditions.
bioRxiv : the preprint server for biology·2026
Luciferase reporter mycobacteriophages for detection, identification, and antibiotic susceptibility testing of Mycobacterium tuberculosis in Mexico.
Journal of clinical microbiology·2001
Transcriptional regulation and immunity in mycobacteriophage Bxb1.
Molecular microbiology·2000
Genome organization and characterization of mycobacteriophage Bxb1.
Molecular microbiology·2000
Targeted Modulation of Lipid Mediator-Biosynthetic Enzymes as Strategy for Inflammation Resolution Pharmacology.
Current topics in microbiology and immunology·2026
Bacterial Infections: Host Defense and Inflammation Resolution Mechanisms for Therapy.
Current topics in microbiology and immunology·2026
Neuronal Guidance Proteins in the Fundamental Biology of Inflammation Resolution.
Current topics in microbiology and immunology·2026
Resolution Failure in Periodontal Diseases: Dysregulated Pro-resolving Mechanisms in Chronic Inflammation and Tissue Breakdown.
Current topics in microbiology and immunology·2026
Resolution Biology in Soft Tissue Joint Disease.
Current topics in microbiology and immunology·2026
A 25+ Year Journey on Yeast-Regulated Cell Death Research.
Current topics in microbiology and immunology·2026
Genomic Characterization and Taxonomic Classification of Mycobacterium shunyiense sp. nov., a Novel Nontuberculous Mycobacterial Species from a Human Respiratory Specimen.
International journal of molecular sciences·2026
Giant Mesenteric Angioleiomyoma: A Rare Case Report.
Annals of African medicine·2026
Modeling Treatment Response in Tuberculosis Early Bactericidal Activity Trials.
CPT: pharmacometrics & systems pharmacology·2026